InvestorsHub Logo

bucweet34

12/20/21 11:27 AM

#197383 RE: chumppunk #197382

But, but, but, Gilead does no wrong. Laughing at the fact that someone would post such nonsense. I guess they should do a little more DD before posting such garbage.

CYDY will rule!!

Maybe they should go back to SA where they spent most of their time telling tall tales.

Hahahahaha.

HyGro

12/20/21 12:49 PM

#197390 RE: chumppunk #197382

The Merck drug failed. Perhaps you should look at Gilead's capsid inhibitor trials -- expected trial 2/28/22, before LL will even be filed.
Safety=placebo. Efficacy 81-95%, LL 81%. Twice a year dosing to 52 times.
Advanced trial for PrEP (no LL PrEP trial even envisioned), HIV mono in advanced development. LL HIV mono???